Related Experiment Video
Updated: Jun 21, 2026

Isolation and Identification of Waterborne Antibiotic-Resistant Bacteria and Molecular Characterization of their Antibiotic Resistance Genes
Published on: March 3, 2023
Antimicrobial development in the era of emerging resistance
Antonio Sorlozano1, Cristina Carrasco, Jose Cabeza
1Department of Microbiology, School of Medicine, Avda de Madrid 11, E-18012 Granada, Spain.
Abstract:
Antibiotics currently under study by the Food and Drugs Administration include: faropenem (for treatment of sinusitis, bronchitis, and community-acquired pneumonia), dalbavancin (for catheter infections), telavancin (for treatment of nosocomial pneumonia), oritavancin (for bacteremia), ceftobiprole and iclaprim (for pneumonias). Moreover, all of them would be useful for skin and soft tissue infections.
More Related Videos
Related Concept Videos
Development of Antibiotic Resistance
Mechanism of Antibiotic Resistance in MRSA
Clinical Significance of Antibiotic Resistance
Antimicrobial Effectiveness
Antibiotic Selection
Microbiota Modulation by Antibiotics

